Vapotherm is a global medical technology company primarily focused on the care of patients suffering from the respiratory distress. Co.'s device solutions are focused on High Velocity Nasal Insufflation (HVNI), which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems such as its Oxygen Assist Module. Co.'s Precision Flow systems include: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Co.'s Precision Flow systems include a capital unit, a single-use disposable and a nasal interface. The VAPO average annual return since 2018 is shown above.
The Average Annual Return on the VAPO average annual return since 2018 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether VAPO average annual return since 2018 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the VAPO average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|